14th edition
| Format |
| HYBRID |
December 2nd & 3rd, 2025
IN-PERSON | STRASBOURG
December 8th ,2025
ONLINE MEETINGS
Investment in immunotherapy in 2018 is still attractive and sought out; what is its growth
potential after several years of being an investment blockbuster? What have been the 2018
investment successes in immunotherapy? Will immunotherapy disrupt the oncology market?
Are we at the growth, maturity, or saturation stage when we talk about investing in
immunotherapy?
With more than 1,200 international actors from 35+ countries, such as big pharma, emerging and small biotech, diagnostic companies, pre-seed / seed / Series A investors, as well as professionals from tech transfer, academia and research institutions, BioFIT is the leading partnering event in Europe for technology transfer, academia-industry collaborations and early-stage innovation deals in the field of Life Sciences. BioFIT is also the European marketplace for pre-seed, seed and Series A investment rounds in Life Sciences.
Learn more
Organised by:
WITH THE SUPPORT OF:
INSTITUTIONAL PARTNERS:
"*" indicates required fields
Parc des exposition de Strasbourg – Hall 1
Avenue Herrenschmidt,
67000, Strasbourg, FRANCE
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
WARNING: Some fraudulent companies are supposedly providing the attendees list of BioFIT. And some are passing themselves off as being BioFIT organisation members and asking you to pay. Please note that the BioFIT team will never sell you the BioFIT attendees list and never ask for your bank account details to make you pay for hotel bookings, exhibition fees or others, and certainly not over the phone.Please be extremely vigilant.